Vericel (VCEL) Liabilities and Shareholders Equity (2010 - 2026)

Vericel has disclosed Liabilities and Shareholders Equity across 17 years of filings, most recently posting $485.6 million for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $485.6 million, up 14.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 14.65% YoY), and the FY2025 annual result was $488.0 million, up 12.77% from the prior year.
• Liabilities and Shareholders Equity came in at $485.6 million for Q1 2026 at Vericel, roughly flat from $488.0 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $488.0 million in Q4 2025 to a low of $240.3 million in Q1 2022.
• The 5-year median for Liabilities and Shareholders Equity is $356.7 million (2024), against an average of $358.7 million.
• Across the five-year window, Liabilities and Shareholders Equity climbed 10.3% in 2022 and jumped 34.54% in 2024, its largest moves.
• Vericel's Liabilities and Shareholders Equity stood at $273.0 million in 2022, then increased by 29.54% to $353.7 million in 2023, then rose by 22.36% to $432.7 million in 2024, then gained by 12.77% to $488.0 million in 2025, then retreated by 0.48% to $485.6 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $485.6 million (Q1 2026), $488.0 million (Q4 2025), and $453.3 million (Q3 2025), per Business Quant data.